Related Experiment Video
Updated: Feb 16, 2026

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
Major Histocompatibility Complex Class I (FLA-E*01801) Molecular Structure in Domestic Cats Demonstrates
Ruiying Liang1, Yaping Sun1, Yanjie Liu1,2
1Department of Microbiology and Immunology, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Insights
Researchers elucidated the structural basis of feline immunodeficiency virus (FIV) peptide presentation by FLA-E*01801, revealing key pocket restrictions for FIV vaccine development. This study identifies potential cytotoxic T lymphocyte (CTL) epitopes for FIV and human immunodeficiency virus (HIV) vaccines.
Area of Science:
- Immunology
- Structural Biology
- Virology
Background:
- Feline immunodeficiency virus (FIV) serves as a natural model for lentiviral infections.
- Understanding feline major histocompatibility complex class I (MHC-I) peptide presentation is crucial for vaccine design.
- FLA-E*01801 is a key molecule in FIV vaccine research.
Purpose of the Study:
- To determine the crystal structure of FLA-E*01801 complexed with an FIV-derived peptide.
- To elucidate the structural basis of peptide binding and identify restrictive elements within the FLA-E*01801 molecule.
- To identify potential cytotoxic T lymphocyte (CTL) epitope peptides from FIV presented by FLA-E*01801.
Main Methods:
- Crystal structure determination of FLA-E*01801 complexed with an FIV gag peptide (RMA9).
- Site-directed mutagenesis and circular dichroism (CD) spectroscopy to investigate peptide binding.
- In vitro refolding experiments to confirm the role of specific amino acid residues.
Main Results:
- The crystal structure revealed that pocket A of FLA-E*01801 restricts peptide binding, particularly at the first position (P1).
- Specific residues (Glu63 and Trp167) in pocket A were identified as critical for restricting P1D binding.
- A binding motif was established: X (except D)-(M/T/A/V/I/L/S)-X-X-X-X-X-X-(R/K), leading to the identification of 125 FIV nonapeptides.
- The study identified potential FIV CTL epitope peptides presented by FLA-E*01801.
Conclusions:
- The structural insights into FLA-E*01801 peptide binding provide a foundation for designing FIV and HIV vaccines.
- Understanding pocket A's restrictive role is vital for selecting appropriate peptide epitopes.
- The identified FIV nonapeptides and binding motif are valuable for developing peptide-based vaccines and further research into MHC-I-peptide interactions.
Abstract:
Feline immunodeficiency virus (FIV) infection in domestic cats is the smallest usable natural model for lentiviral infection studies. FLA-E*01801 was applied to FIV AIDS vaccine research. We determined the crystal structure of FLA-E*01801 complexed with a peptide derived from FIV (gag positions 40 to 48; RMANVSTGR [RMA9]). The A pocket of the FLA-E*01801 complex plays a valuable restrictive role in peptide binding. Mutation experiments and circular-dichroism (CD) spectroscopy revealed that peptides with Asp at the first position (P1) could not bind to FLA-E*01801. The crystal structure and in vitro refolding of the mutant FLA-E*01801 complex demonstrated that Glu63 and Trp167 in the A pocket play important roles in restricting P1D. The B pocket of the FLA-E*01801 complex accommodates M/T/A/V/I/L/S residues, whereas the negatively charged F pocket prefers R/K residues. Based on the peptide binding motif, 125 FLA-E*01801-restricted FIV nonapeptides (San Diego isolate) were identified. Our results provide the structural basis for peptide presentation by the FLA-E*01801 molecule, especially A pocket restriction on peptide binding, and identify the potential cytotoxic T lymphocyte (CTL) epitope peptides of FIV presented by FLA-E*01801. These results will benefit both the reasonable design of FLA-E*01801-restricted CTL epitopes and the further development of the AIDS vaccine.IMPORTANCE Feline immunodeficiency virus (FIV) is a viral pathogen in cats, and this infection is the smallest usable natural model for lentivirus infection studies. To examine how FLA I presents FIV epitope peptides, we crystallized and solved the first classic feline major histocompatibility complex class I (MHC-I) molecular structure. Surprisingly, pocket A restricts peptide binding. Trp167 blocks the left side of pocket A, causing P1D to conflict with Glu63 We also identified the FLA-E*01801 binding motif X (except D)-(M/T/A/V/I/L/S)-X-X-X-X-X-X-(R/K) based on structural and biochemical experiments. We identified 125 FLA-E*01801-restricted nonapeptides from FIV. These results are valuable for developing peptide-based FIV and human immunodeficiency virus (HIV) vaccines and for studying how MHC-I molecules present peptides.
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Viral Structure
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

